|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09.01.26 - 15:12
|
Enhanced Genomics Appoints Dr Katerina Leftheris to Its Board of Directors (Business Wire)
|
|
|
Experienced leader in preclinical and clinical drug development will support expansion of Company's therapeutics pipeline for complex and common genetic diseasesCAMBRIDGE, England--(BUSINESS WIRE)--Enhanced Genomics ('Enhanced' or 'the Company'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced Katerina Leftheris, Ph.D. has joined its Board of Directors. Katerina's appointment as a Director forms part of the Company's ongoing strategy to expand its internal therapeutics pipeline for drug targets identified using its 3D multi-omics platform.
Katerina is an experienced scientific and executive leader, with over 30 years of experience in senior scientific positions in large pharma and biotech companies, including Bristol Myers Squibb (BMS), Celgene (acquired by BMS), and Pliant Therapeutics, during which time she led discovery and development programs to advance 15 compounds into clinical de...
|
|
|
|
|
|
|
01.12.25 - 14:33
|
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference (GlobeNewswire EN)
|
|
|
SOUTH SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today announced its participation in the Piper Sandler 37th Annual Healthcare Conference to be held December 2 – 4, 2025.Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, Keith Cummings, M.D., Chief Financial Officer and Éric Lefebvre, M.D., Chief Medical Officer, will participate in a fireside chat on Thursday, December 4, 2025, at 12:30 p.m. Eastern Time. Interested parties may access the live webcast of the fireside chat by visiting here or the Investor Relations' Events & Presentation page of Pliant's website. The webcast replay will be archived on the Pliant website for 90 days following the conclusion of the event....
|
|
|
|
|
10.09.25 - 06:45
|
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz (RTTNews)
|
|
|
Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor conference appearances. Companies like Immutep, Nautilus Biotechnology, Pliant Therapeutics, Phio Pharmaceuticals, and Kura Oncology all saw renewed momentum, driven by near-term catalysts that are drawing ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
